ArticleFrontiers in public health2026
Establishing an EU-compliant diagnostic facility for infectious diseases under war conditions in Poltava, Ukraine.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Carbapenem-resistant Enterobacterales in Europe: strengthening AMR resilience through coordinated system-level action - lessons from Ukraine.Antimicrobial resistance and infection control · 2026Review
- Regional and Seasonal Dynamics of Leptospirosis in Ukraine, 2023-2025.Pathogens (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Russia's invasion has systematically destroyed Ukrainian healthcare infrastructure while simultaneously increasing infectious disease risks through wounded combatants and civilians, people displacement, and disrupted care. Poltava, a central region hosting over 200,000 internally displaced persons, already faced pre-war infectious disease incidences higher than the national average, yet diagnostics relied mostly on low-sensitivity rapid tests. Through a German-Ukrainian hospital partnership funded by the Deutsche Gesellschaft für Internationale Zusammenarbeit, we established EU-compliant infectious disease serology (ELFA) and automated PCR, as well as an automated bacterial identification system with antibiotic susceptibility testing in Poltava's Regional Clinical Infectious Diseases Hospital. Key elements of the partnership included participatory equipment selection, intensive hands-on training of Ukrainian staff in Germany, joint standard operating procedures, and adaptive reagent supply. Between March 2024 and June 2025, the laboratories in Poltava performed 16,633 tests, detecting previously unrecognized HIV, Hepatitis B and C, Lyme disease, Toxoplasmosis, and antibiotic-resistant bacterial infections. This project demonstrates that advanced diagnostic capacities can be established under war conditions when partnership design prioritizes easy and strait forward solutions, shared decision-making, and contingency planning. The prototypical establishment of powerful serological and molecular diagnostics in infectious diseases through this German-Ukrainian partnership may serve as a model for the implementation in other regions of the Ukraine. Even under the difficult conditions of war, this advancement in infectious disease diagnostics allows for more targeted patient care and contributes to the prevention of pathogen transmission in the Ukraine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.